FindTrial
Sign In

Analysis of bile for gall bladder and bile duct cancers.

Diagnostic value of cell free tumor DNA in bile and its relation to biliary bile acids for Biliary Tract Carcinoma. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067223
Enrollment
90
Registered
2024-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Institute of liver and biliary sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All biliary tract carcinomas, benign biliary diseases with high risk features for biliary carcinomas, symptomatic Gallstone disease.

Exclusion criteria

Exclusion criteria: Negative consent Inability to collect adequate bile sample.

Design outcomes

Primary

MeasureTime frame
Total cell free DNA Genetic mutations in bile cell free tumor DNA.Timepoint: one year—

Secondary

MeasureTime frame
Proportion of primary and secondary and tertiary bile acids in bile. Histopathological staging and grading and level of tumor markers of the Biliary tract cancers.Timepoint: one year—

Countries

India

Contacts

Public ContactDr Nihar Ranjan Mohapatra

Institute of Liver and Biliary Sciences

NIHAR0310@GMAIL.COM9910479799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026